4th Danish Conference on Biotechnology and Molecular Biology:
“Biomarker discovery and drug development in the omics era”
May 28 - 29, 2009. Hotel Munkebjerg, Vejle.
Organized by Danish Biotechnological Society and Danish Biochemical Society
Sponsored by Novozymes
Thursday May 28, 2009
Session 1: Chemical genomics and drug development
Ulrik Gether, Institute of Neuroscience and Pharmacology, University of Copenhagen:
Pharmacogenomics of receptors and transporters in the nervous system.
Michael Sundström, The Novo Nordisk Foundation Center for Protein Research,
University of Copenhagen: Insights for the Development of Kinase inhibitors using
Systematic Screening Approaches.
Session 2: Plant biotechnology
Keynote Lecture: Birger Lindberg Møller, Institute for Plant Biology and Biotechnology,
Faculty of Life Sciences, University of Copenhagen: Bio-active plant natural products:
diversity and possibilities.
Session 3: Biomarkers for human diseases: From discovery to applications
Anne-Christine Bay Jensen, Nordic Bioscience A/S, Herlev: Neoepitopes: from discovery
to application in bone and cartilage disorders.
Martin R. Larsen, Protein Research, Institute for Biochemistry and Molecular Biology,
University of Southern Denmark: Proteomics approaches for identification of biomarkers in
Børge Nordestgaard, Herlev Hospital and University of Copenhagen: Biomarkers,
genetics and risk factors in cardiovascular disesase.
Session 4: Nanobioscience and drug delivery
Yechezkel Barenholtz, Laboratory of Liposome and Membrane Research, Department of
Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel: From
nanotechnology and nanobio to nanomedicine and nanodrugs: our liposome experience.
Ole G. Mouritsen, MEMPHYS-Center for Biomembrane Physics, Department of Physics
and Chemistry, University of Southern Denmark: Enzymatic triggering in liposome-based
Session 5: Plants, microbes and bioactive compounds
Christian Hertweck, Leibniz Institute for Natural Product Research and Infection Biology,
Hans Knöll Institute, Jena, Germany: Rational pathway engineering towards novel
bioactive natural compounds.
Jørgen Hansen, Evolva A/S, Frederiksberg, Copenhagen: Watchmaker- A Genetic
Chemistry Approach to Drug Discovery.
Friday May 29, 2009
Session 6: Structural biology and drug design
Poul Nissen, Department of Molecular Biology, University of Aarhus: The structural basis
of ion transport by membrane pumps.
Jesper Wengel, Nucleic Acid Center, University of Southern Denmark: LNA (Locked
Nucleic Acid) and UNA (Unlocked Nucleic Acid).
Irina Kouskoumvekaki, Center for Biological Sequence Analysis, Technical University of
Denmark: Chemoinformatics in drug discovery.
Session 7: Structural biology and drug discovery
Keynote Lecture: Tom Blundell, Department of Biochemistry, University of Cambridge,
United Kingdom: Genomes, structural biology and drug discovery: exploring biological and
Session 8: Antibody-based therapeutics.
Jørgen Petersen, Genmab, Copenhagen K: anti-CD20 antibodies in cancer treatment.
Anne Bondgaard Tolstrup, Antibody Expression, Symphogen, Lyngby: Polyclonal
antibodies in the treatment of cancer.
Jan Trøst Jørgensen, CMC Contrast, Abscion DTU, Lyngby: A model for drug-diagnostic
co-development – Trastuzumab (Herceptin) and HercepTest.
Program and Registration on-line: www.biokemi.org or www.ida.dk
Regular fee: Members of DBS or DSBMB 3200 Kr. Non-members 3700 Kr. Reduced fee
for Ph.D. and Master Students: Members of DBS or DSBMB 1600 Kr. Non-members 2100
Kr. One-day participants 800 Kr. Number of participants is limited to 150. Deadline for
registration and abstracts: May 1, 2009.
Master and Ph.D. Students can apply for Fellowship, which covers the registration fee.
Application on-line: www.biokemi.org
Vendor exhibition contact
Vivian Juhl, Department of Clinical Biochemistry, Glostrup Hospital, 2600 Glostrup, Tlf.:
4323 2458, Fax: 4323 3929, e-mail: firstname.lastname@example.org
Birgitte Magnér-Egeberg, Ingeniørforeningen i Danmark (IDA), Netværkscenter, Kalvebod
Brygge 31 – 33, 1780 København V, Tlf.: 33 18 46 46, e-mail: email@example.com